NK
Naresh Kumar Goel
About Naresh Kumar Goel
Data last updated:
Naresh Kumar Goel is a Director at Recova Pharma Expo Private Limited (since 2006), Director at Austro Labs Limited (since 2014) and Director at Shrish Enterprises Private Limited (since 2000), and holds 6 more current directorships. The companies operate in Pharma, Healthcare and Business Outsourcing. The 7 current companies with reported revenue have a combined latest revenue of ₹324 Cr; the largest is Recova Pharma Expo Private Limited at ₹111 Cr (FY 2025). Earlier, Naresh Kumar Goel was a Director at Warner (India) Pharma Private Limited (2007–2010) and Director at Knoll Pharmaceuticals Limited (2005–2011) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Mar 2006 | 2006 | ₹111 Cr (FY 2025) | Active | |
| Director | 31 Jan 2014 | 2013 | ₹76.29 Cr (FY 2024) | Active | |
| Director | 23 Mar 2000 | 2000 | ₹74.62 Cr (FY 2025) | Active | |
| Director | 02 Feb 2010 | 2010 | ₹24.79 Cr (FY 2025) | Active | |
| Director | 31 May 2022 | 2011 | ₹22.16 Cr (FY 2025) | Active | |
| Director | 12 Mar 1999 | 1999 | ₹15.27 Cr (FY 2025) | Active | |
| Director | 25 Feb 2016 | 2016 | ₹89,387 (FY 2025) | Active | |
| Partner | 03 Aug 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Dec 2007 | 2007 | ₹34.07 Cr (FY 2025) | Active | |
| Director | 19 Sep 2005 | 2005 | ₹13.12 Cr (FY 2025) | Active | |
| Director | 03 Dec 2009 | 2009 | ₹16.4 Lakh (FY 2024) | Active | |
| Director | 13 Apr 2009 | 2008 | ₹3.9 Lakh (FY 2024) | Amalgamated | |
| Director | 09 May 2008 | 2008 | ₹35.2 Lakh (FY 2025) | Active | |
| Director | 28 Jun 2010 | 2008 | ₹35.7 Lakh (FY 2026) | Active | |
| Director | 11 Dec 2007 | 2007 | ₹23 Lakh (FY 2025) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Naresh Kumar Goel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gyanesh Jeswal | 01646875 | Recova Pharma Expo Private Limited , Warner India Lifesciences Limited | Director |
| Ramesh Kumar Goel | 00413567 | Recova Pharma Expo Private Limited , Shrish Enterprises Private Limited and 4 more | Director |
| Ashok Kumar Agarwal | 00243528 | Austro Labs Limited | Director |
| Mohit Goel | 06719544 | Austro Labs Limited , Sentosa Geigy (India) Labs Limited and 2 more | Director |
| Vaibhav | 06708694 | Austro Labs Limited | Director |
| Ashutosh Goel | 07681430 | Cogni Labs Limited , Cogni Pharmaceuticals Llp | Director |
| Mayank Goel | 07681467 | Cogni Labs Limited , Cogni Pharmaceuticals Llp | Director |
| Pranav Trikha | 05012045 | Cogni Labs Limited | Director |
| Geeta Devi Goel | 06890608 | Cogni Pharmaceuticals Llp | Partner |
| Pinki Goel | 06890625 | Cogni Pharmaceuticals Llp | Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naresh Kumar Goel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naresh Kumar Goel
Naresh Kumar Goel currently holds 9 directorships: Recova Pharma Expo Private Limited (Director, since 20 Mar 2006, revenue ₹111 Cr (FY 2025)); Austro Labs Limited (Director, since 31 Jan 2014, revenue ₹76.29 Cr (FY 2024)); Shrish Enterprises Private Limited (Director, since 23 Mar 2000, revenue ₹74.62 Cr (FY 2025)); Sentosa Geigy (India) Labs Limited (Director, since 02 Feb 2010, revenue ₹24.79 Cr (FY 2025)); Warner India Lifesciences Limited (Director, since 31 May 2022, revenue ₹22.16 Cr (FY 2025)); and 4 more.
Naresh Kumar Goel was first appointed on 12 Mar 1999 as Director at Gangesh Pharma Private Limited. The most recent appointment on record is 03 Aug 2026 at Cogni Pharmaceuticals Llp.
The 7 current companies of Naresh Kumar Goel that report revenue have a combined latest revenue of ₹324 Cr: Recova Pharma Expo Private Limited ₹111 Cr (FY 2025); Austro Labs Limited ₹76.29 Cr (FY 2024); Shrish Enterprises Private Limited ₹74.62 Cr (FY 2025); Sentosa Geigy (India) Labs Limited ₹24.79 Cr (FY 2025); Warner India Lifesciences Limited ₹22.16 Cr (FY 2025); and 2 more.
Naresh Kumar Goel held 7 earlier board appointments: Warner (India) Pharma Private Limited (Director, 13 Dec 2007 to 22 Mar 2010); Knoll Pharmaceuticals Limited (Director, 19 Sep 2005 to 03 Nov 2011); Helax Probic Private Limited (Director, 03 Dec 2009 to 03 Jan 2012); Astra Medica Private Limited (Director, 13 Apr 2009 to 06 Jun 2014); Medial Pharma Limited (Director, 09 May 2008 to 06 Jun 2014); and 2 more.
The current boards of Naresh Kumar Goel's companies include Gyanesh Jeswal (Recova Pharma Expo Private Limited), Ramesh Kumar Goel (Recova Pharma Expo Private Limited), Ashok Kumar Agarwal (Austro Labs Limited), Mohit Goel (Austro Labs Limited), Vaibhav (Austro Labs Limited), Ashutosh Goel (Cogni Labs Limited), among others.